TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

LATEST NEWS

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
Play
HEALTH

Best Biotech Stocks to Buy in 2021

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap (Wednesday 8/2/17)
JIM CRAMER

Resist All the Dow 22K Hoopla: Cramer's 'Mad Money' Recap

Comcast, Synergy Pharmaceuticals, Chipotle, Blackstone Group: 'Mad Money' Lightning Round
JIM CRAMER

Comcast, Synergy Pharmaceuticals, Chipotle, Blackstone Group: 'Mad Money' Lightning Round

Our Trips to This Whole Foods Store Were Astonishing and a Big Reminder Why Amazon Must Clean House
JIM CRAMER

Amazon's Disruptive Deal for Whole Foods: Cramer's 'Mad Money' Recap

Shire Gains as it Seeks European Approval For Dry Eye Treatment
STOCKS

Biotech Movers: Shire Shares Fall After Giving Up on Stem Cell Transplant Treatment

Mallinckrodt Spikes on Positive Regenerative Tissue Treatment Results
HEALTH

Biotech Movers: Synergy Pharmaceuticals Explodes 15%, and Bluebird Bio May Be Next

The 10 Worst-Performing S&P 500 Stocks in June
HEALTH

Biotech Movers: Synergy, Biogen, Insys

Innoviva Says It Fends Off Sarissa Dissidents
STOCKS

Neurocrine Biosciences Leads Pre-Market Biotech Movers

Innoviva Says It Fends Off Sarissa Dissidents
STOCKS

Trevena, Synergy Lead Biotech Movers

How to Trade Hot Stocks Apple, Seadrill, Advanced Micro Devices
STOCKS

How to Trade Hot Stocks Apple, Seadrill, Advanced Micro Devices

Biotech Movers: Lion Biotechnologies, XBiotech, Halozyme
HEALTH

Premarket biotech movers: Synergy, Arrowhead, BioCryst

Calling an Audible; The Merits of Contrarian Thinking: Best of Kass
INVESTING

Bristol-Myers Squibb, Merck, Synergy Pharmaceuticals: Doug Kass' Views

Synergy Pharmaceuticals Secures Approval for Linzess Competitor
STOCKS

Synergy Pharmaceuticals secures approval for Linzess competitor

I'm Not Buying a 'Sell the News' Inauguration Trade
FUTURES

Futures, Asia mixed as investors ponder the new president

Western Digital Soon a Low-Risk Buy
JIM CRAMER

Western Digital, Twilio, AT&T: 'Mad Money' Lightning Round (Friday 1/6/17)

Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)
JIM CRAMER

Health Care, Banks Lead Game Strategy for Next Week: Cramer's 'Mad Money' Recap (Friday 1/6/17)

Micron Technology Names Sanjay Mehrotra CEO, President
STOCKS

How to Trade the Week's Most Active Stocks -- Micron, Nvidia, Synergy Pharma and More

Futures Mixed Ahead of Holiday Weekend; Asia Opened Lower
FUTURES

Futures mixed ahead of holiday weekend; Asia opened lower

Pfizer's Poor Earnings Feed the Allergan Tie-Up Fire
STOCKS

Lack of catalysts keeps analysts away from Pfizer

Exact Sciences in Talks to Buy Genomic Health - Report
STOCKS

7 stocks under $10 making big moves higher

BioCryst Pill Prevents Swelling Attacks but Shares Fall on Competitive Concerns
MARKETS

Here's a Reason Why Synergy Pharma (SGYP) Stock Is Rallying Today

'Mad Money' Lightning Round: JetBlue Has No Upside
JIM CRAMER

'Mad Money' Lightning Round: JetBlue Has No Upside

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week
JIM CRAMER

Jim Cramer's 'Mad Money' Recap: I'm Watching Best Buy, PVH, Yellen This Week

Roger Ailes, Biogen Shake-Up and Other Notable CEO Departures of 2016
MERGERS AND ACQUISITIONS

Biogen should either a buyer or a seller be

10 Highest-Paying Jobs in 2016 If All You Care About Is Money
INVESTING

Here Are Some Small-Cap Pharma M&A Targets After Relypsa Deal